Evaluation of oral iron treatment in pediatric restless legs syndrome (RLS)

Sleep Medicine
Ikuko MohriMasako Taniike

Abstract

We conducted a retrospective chart review of children with restless legs syndrome (RLS) to evaluate the efficacy of oral iron treatment, which was administered open-label during the course of clinical care. In addition, we provided detailed clinical information about RLS in this pediatric cohort. The study included 30 consecutive Japanese children with RLS who visited the Pediatric Sleep Clinic at Osaka University Hospital, and consisted of 17 boys and 13 girls, aged 2-14 years (mean ± SD, 6.5 ± 2.8). All-night polysomnography was performed in 18 patients and serum ferritin levels were measured in all the patients. After the diagnosis of RLS, iron was administered at doses between 1.6 and 7.8 mg/kg/day (3.2 ± 1.3). Serum ferritin was re-evaluated 3-6 months after iron treatment, or when RLS symptoms had disappeared. The patient age at onset of RLS symptoms ranged from six months to 13 years (4.3 ± 3.6). A positive family history was recognized in 19 children (63.3%). Serum ferritin levels before therapy were 9-62 ng/ml (26.6 ± 12.8) and oral iron supplementation was reported to be highly effective in 17 children, effective in 10, and ineffective in three. The serum ferritin level at follow-up was 23-182 ng/ml (83.5 ± 49.8). The...Continue Reading

References

Jul 23, 2005·Annals of Neurology·Christoph SchmidauerWerner Poewe
Jun 15, 2007·Movement Disorders : Official Journal of the Movement Disorder Society·Richard P Allen, Christopher J Earley
Jun 26, 2007·Movement Disorders : Official Journal of the Movement Disorder Society·Stephany Fulda, Thomas C Wetter
Oct 13, 2007·Brain : a Journal of Neurology·Stephany Fulda, Thomas C Wetter
Jan 14, 2009·Sleep Medicine·Christopher J Earley
Feb 3, 2009·Sleep Medicine Reviews·Narong SimakajornboonDavid Gozal
Jun 3, 2009·Movement Disorders : Official Journal of the Movement Disorder Society·Ludger GroteJan Ulfberg
Jun 10, 2010·Nature Reviews. Neurology·Claudia Trenkwalder, Walter Paulus
Jun 18, 2010·European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society·James E JanMichael B Wasdell
Sep 30, 2010·Developmental Medicine and Child Neurology·Kutluhan YilmazDeniz Kor
Feb 23, 2011·Sleep Medicine·Dilşad TurkdoganSennur Zaimoglu

❮ Previous
Next ❯

Citations

Sep 23, 2014·Current Treatment Options in Neurology·William G Ondo
Oct 12, 2012·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Shannon S Sullivan
Aug 28, 2012·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Mark J Buchfuhrer
Jan 31, 2013·Acta Paediatrica·Jens TilmaJohn R Ostergaard
Oct 21, 2015·Sleep Science·Paulo Daubian-NoséAndrea Maculano Esteves
Oct 25, 2013·Sleep Medicine·David G Ingram, David T Plante
Dec 24, 2013·Journal of the Neurological Sciences·Naomichi FurudateYuichi Inoue
Jul 25, 2019·Indian Journal of Ophthalmology·Nawazish ShaikhPradeep Venkatesh
Jan 5, 2019·The Cochrane Database of Systematic Reviews·Lynn M Trotti, Lorne A Becker
Aug 27, 2017·Movement Disorders : Official Journal of the Movement Disorder Society·Yuan-Yang LaiJerome M Siegel
Aug 24, 2017·Paediatric Drugs·Geoffrey RulongNarong Simakajornboon
Apr 1, 2020·Sleep Medicine Reviews·Wayne LeungOsman S Ipsiroglu
Feb 12, 2021·Journal of Clinical Sleep Medicine : JCSM : Official Publication of the American Academy of Sleep Medicine·Seong Min OhYu Jin Lee
May 15, 2021·Sleep Medicine Clinics·Rosalia Silvestri, Lourdes M DelRosso

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anemia

Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.